Affiliation:
1. SSM Health Dean Medical Group, Madison, Wisconsin,
2. Oakwood Preferred, Madison, Wisconsin
Abstract
ABSTRACT
Background:
In post-acute care (PAC) settings, residents face elevated risks of adverse drug reactions and emergency department visits because of polypharmacy. With over 90% of PAC residents nationally taking five or more medications, targeted deprescribing of inappropriate or unnecessary medications emerges as a critical strategy.
Local problem:
The project site faces high rates of polypharmacy with a root cause analysis revealing a deficiency in evidence-based practices (EBP) for deprescribing potentially inappropriate or unnecessary medications. To address this issue, a bundled deprescribing intervention was implemented as part of a quality improvement project aimed at reducing polypharmacy rates.
Methods:
This project, conducted at a PAC setting in the midwestern United States, used the RE-AIM Model. Data collection involved tracking prescribing rates before and after the intervention for residents admitted to the practice setting over a 5-month period.
Intervention:
A bundled EBP intervention comprising a deprescribing framework, pharmacist collaboration, and the utilization of an EBP guideline, established a systematic process guiding deprescribing efforts for each resident on admission to the PAC setting.
Results:
Fourty-nine patients received a deprescribing bundle, resulting in a 26.67% reduction in prescribed medications. On average, patients had 5.55 medications deprescribed, with reductions noted across 85 distinct therapeutic drug categories.
Conclusion:
Nurse practitioners play a pivotal role initiating successful deprescribing interventions within the PAC setting. Using a comprehensive approach, integrating pharmacist collaboration and EBP leads to reductions in prescribing rates among PAC residents. This model demonstrates potential for sustainable improvements in patient outcomes within the PAC environment.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference29 articles.
1. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: A randomized controlled trial;Balsom;International Journal of Clinical Pharmacy,2020
2. Polypharmacy: Misleading, but manageable;Buchardt;Clinical Interventions in Aging,2008
3. Polypharmacy in the elderly—When good drugs lead to bad outcomes: A teachable moment;Carroll;Journal of the American Medical Association,2017
4. Effects of an interprofessional quality circle-deprescribing module (QC-DeMo) in Swiss nursing homes: A randomised controlled trial;Cateau;BioMedCentral Geriatrics,2021
5. Deprescribing as a clinical improvement focus;Dharmarajan;Journal of the American Medical Directors Association,2020